Annual ROE
-37.78%
-5.83%-18.25%
December 31, 2023
Summary
- As of February 7, 2025, SNDX annual return on equity is -37.78%, with the most recent change of -5.83% (-18.25%) on December 31, 2023.
- During the last 3 years, SNDX annual ROE has risen by +13.78% (+26.73%).
- SNDX annual ROE is now -110.89% below its all-time high of 346.89%, reached on December 31, 2014.
Performance
SNDX ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
-67.33%
-8.37%-14.20%
September 30, 2024
Summary
- As of February 7, 2025, SNDX quarterly return on equity is -67.33%, with the most recent change of -8.37% (-14.20%) on September 30, 2024.
- Over the past year, SNDX quarterly ROE has dropped by -23.32% (-52.99%).
- SNDX quarterly ROE is now -104.32% below its all-time high of 1560.17%, reached on March 31, 2015.
Performance
SNDX Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
SNDX ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -18.3% | -53.0% |
| 3 y3 years | +26.7% | -1340.0% |
| 5 y5 years | +59.8% | -1340.0% |
SNDX ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -600.4% | at low | -803.5% | at low |
| 5 y | 5-year | -600.4% | +71.5% | -803.5% | +40.2% |
| alltime | all time | -110.9% | +71.5% | -104.3% | +96.2% |
Syndax Pharmaceuticals ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -67.33%(+14.2%) |
| Jun 2024 | - | -58.96%(+9.8%) |
| Mar 2024 | - | -53.69%(+13.7%) |
| Dec 2023 | -37.78%(+18.2%) | -47.23%(+7.3%) |
| Sep 2023 | - | -44.01%(+10.0%) |
| Jun 2023 | - | -40.02%(+3.3%) |
| Mar 2023 | - | -38.76%(+1.3%) |
| Dec 2022 | -31.95%(-523.2%) | -38.28%(+822.4%) |
| Sep 2022 | - | -4.15%(-1696.2%) |
| Jun 2022 | - | 0.26%(-95.2%) |
| Mar 2022 | - | 5.43%(-43.3%) |
| Dec 2021 | 7.55%(-114.6%) | 9.57%(-121.4%) |
| Sep 2021 | - | -44.69%(-4.8%) |
| Jun 2021 | - | -46.94%(-10.8%) |
| Mar 2021 | - | -52.64%(-11.2%) |
| Dec 2020 | -51.56%(-61.1%) | -59.29%(-27.4%) |
| Sep 2020 | - | -81.63%(-8.3%) |
| Jun 2020 | - | -89.03%(-20.9%) |
| Mar 2020 | - | -112.59%(+1.5%) |
| Dec 2019 | -132.43% | -110.94%(+4.0%) |
| Sep 2019 | - | -106.71%(+1.7%) |
| Jun 2019 | - | -104.94%(+4.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2019 | - | -100.31%(+2.8%) |
| Dec 2018 | -94.00%(+45.7%) | -97.59%(+11.1%) |
| Sep 2018 | - | -87.82%(+14.1%) |
| Jun 2018 | - | -76.95%(+7.6%) |
| Mar 2018 | - | -71.53%(+9.9%) |
| Dec 2017 | -64.53%(+9.4%) | -65.08%(+13.2%) |
| Sep 2017 | - | -57.50%(+2.3%) |
| Jun 2017 | - | -56.20%(+12.3%) |
| Mar 2017 | - | -50.05%(+4.6%) |
| Dec 2016 | -58.97%(-25.4%) | -47.84%(+11.0%) |
| Sep 2016 | - | -43.11%(-4.2%) |
| Jun 2016 | - | -45.02%(-25.9%) |
| Mar 2016 | - | -60.78%(+73.2%) |
| Dec 2015 | -79.10%(-122.8%) | -35.09%(-49.1%) |
| Sep 2015 | - | -68.89%(-112.7%) |
| Jun 2015 | - | 541.23%(-65.3%) |
| Mar 2015 | - | 1560.17%(-187.5%) |
| Dec 2014 | 346.89%(-390.0%) | -1782.69%(+376.1%) |
| Sep 2014 | - | -374.43%(+73.1%) |
| Jun 2014 | - | -216.28%(+28.6%) |
| Mar 2014 | - | -168.17%(+40.6%) |
| Dec 2013 | -119.60%(-451.6%) | -119.60% |
| Dec 2012 | 34.02% | - |
FAQ
- What is Syndax Pharmaceuticals annual return on equity?
- What is the all time high annual ROE for Syndax Pharmaceuticals?
- What is Syndax Pharmaceuticals annual ROE year-on-year change?
- What is Syndax Pharmaceuticals quarterly return on equity?
- What is the all time high quarterly ROE for Syndax Pharmaceuticals?
- What is Syndax Pharmaceuticals quarterly ROE year-on-year change?
What is Syndax Pharmaceuticals annual return on equity?
The current annual ROE of SNDX is -37.78%
What is the all time high annual ROE for Syndax Pharmaceuticals?
Syndax Pharmaceuticals all-time high annual return on equity is 346.89%
What is Syndax Pharmaceuticals annual ROE year-on-year change?
Over the past year, SNDX annual return on equity has changed by -5.83% (-18.25%)
What is Syndax Pharmaceuticals quarterly return on equity?
The current quarterly ROE of SNDX is -67.33%
What is the all time high quarterly ROE for Syndax Pharmaceuticals?
Syndax Pharmaceuticals all-time high quarterly return on equity is 1560.17%
What is Syndax Pharmaceuticals quarterly ROE year-on-year change?
Over the past year, SNDX quarterly return on equity has changed by -23.32% (-52.99%)